• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病突变如何影响正常壁厚度携带者的心肌功能?心血管磁共振评估。

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.

机构信息

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

出版信息

J Cardiovasc Magn Reson. 2010 Mar 15;12(1):13. doi: 10.1186/1532-429X-12-13.

DOI:10.1186/1532-429X-12-13
PMID:20230637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2842263/
Abstract

BACKGROUND

Clinical data on myocardial function in HCM mutation carriers (carriers) is sparse but suggests that subtle functional abnormalities can be measured with tissue Doppler imaging before the development of overt hypertrophy. We aimed to confirm the presence of functional abnormalities using cardiovascular magnetic resonance (CMR), and to investigate if sensitive functional assessment could be employed to identify carriers.

RESULTS

28 carriers and 28 controls were studied. Global left atrial (LA) and left ventricular (LV) dimensions, segmental peak systolic circumferential strain (SCS) and peak diastolic circumferential strain rate (DCSR), as well as the presence of late Gadolinium enhancement (LGE) were determined with CMR. Septal and lateral myocardial velocities were measured with echocardiographic tissue Doppler imaging. LV mass and volumes were comparable between groups. Maximal septal to lateral wall thickness ratio (SL ratio) was larger in carriers than in controls (1.3+/-0.2 versus 1.1+/-0.1, p<0.001). Also, LA volumes were larger in carriers compared to controls (p<0.05). Both peak SCS (p<0.05) and peak DCSR (p<0.01) were lower in carriers compared to controls, particularly in the basal lateral wall. Focal LGE was present in 2 carriers and not in controls. The combination of a SL ratio>1.2 and a peak DCSR<105%.s-1 was present in 45% of carriers and in none of the controls, yielding a positive predictive value of 100%. Two carriers and 18 controls had a SL ratio<1.2 and peak DCSR>105%.s-1, yielding a negative predictive value of 90%. With multivariate analysis, HCM mutation carriership was an independent determinant of reduced peak SCS and peak DCSR.

CONCLUSIONS

HCM mutation carriership is an independent determinant of reduced peak SCS and peak DCSR when LV wall thickness is within normal limits, and is associated with increased LA volumes and SL ratio. Using SL ratio and peak DCSR has a high accuracy to identify carriers. However, since carriers also display structural abnormalities and focal LGE, we advocate to also evaluate morphology and presence of LGE when screening for carriers.

摘要

背景

肥厚型心肌病(HCM)突变携带者的心肌功能临床数据很少,但提示在明显肥大发生之前,组织多普勒成像可以测量到微妙的功能异常。我们旨在使用心血管磁共振(CMR)证实存在功能异常,并研究敏感的功能评估是否可用于识别携带者。

结果

研究了 28 名携带者和 28 名对照者。使用 CMR 确定了左心房(LA)和左心室(LV)的整体尺寸、节段性峰值收缩周向应变(SCS)和峰值舒张周向应变率(DCSR),以及晚期钆增强(LGE)的存在。使用超声心动图组织多普勒成像测量了间隔和侧壁心肌速度。LV 质量和容量在两组之间相似。携带者的最大间隔到侧壁厚度比(SL 比)大于对照组(1.3±0.2 与 1.1±0.1,p<0.001)。此外,携带者的 LA 容积大于对照组(p<0.05)。与对照组相比,携带者的峰值 SCS(p<0.05)和峰值 DCSR(p<0.01)均较低,尤其是在基底侧壁。2 名携带者存在局灶性 LGE,而对照组没有。SL 比>1.2 和峰值 DCSR<105%.s-1 的组合存在于 45%的携带者中,而对照组中不存在,阳性预测值为 100%。2 名携带者和 18 名对照组的 SL 比<1.2 和峰值 DCSR>105%.s-1,阴性预测值为 90%。多变量分析显示,HCM 突变携带者是 LV 壁厚度正常范围内峰值 SCS 和峰值 DCSR 降低的独立决定因素。

结论

当 LV 壁厚度在正常范围内时,HCM 突变携带者是峰值 SCS 和峰值 DCSR 降低的独立决定因素,与 LA 容积增加和 SL 比增加相关。使用 SL 比和峰值 DCSR 具有很高的准确性来识别携带者。然而,由于携带者也显示出结构异常和局灶性 LGE,因此我们主张在筛选携带者时,也评估形态和 LGE 的存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/313763492930/1532-429X-12-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/1a3b00e0327f/1532-429X-12-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/2a401324b2d8/1532-429X-12-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/15039fe315cf/1532-429X-12-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/313763492930/1532-429X-12-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/1a3b00e0327f/1532-429X-12-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/2a401324b2d8/1532-429X-12-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/15039fe315cf/1532-429X-12-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f943/2842263/313763492930/1532-429X-12-13-4.jpg

相似文献

1
How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.肥厚型心肌病突变如何影响正常壁厚度携带者的心肌功能?心血管磁共振评估。
J Cardiovasc Magn Reson. 2010 Mar 15;12(1):13. doi: 10.1186/1532-429X-12-13.
2
Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.肥厚型心肌病肌节突变携带者左心房结构和功能与左心室肥厚的关系。
J Cardiovasc Magn Reson. 2017 Dec 28;19(1):107. doi: 10.1186/s12968-017-0420-0.
3
Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.在肥厚型心肌病中,左心房纤维化与左心室心肌延迟强化程度及左心室应变相关。
Int J Cardiovasc Imaging. 2019 Jul;35(7):1309-1318. doi: 10.1007/s10554-019-01551-7. Epub 2019 Feb 21.
4
CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.肥厚型心肌病合并心房颤动患者的心脏磁共振成像结果
J Cardiovasc Magn Reson. 2009 Sep 9;11(1):34. doi: 10.1186/1532-429X-11-34.
5
Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.心血管磁共振斑点追踪成像技术评估非梗阻性肥厚型心肌病患者左心房功能:一项可行性和可重复性研究。
J Cardiovasc Magn Reson. 2020 Jan 2;22(1):1. doi: 10.1186/s12968-019-0589-5.
6
Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.携带PRKAG2基因突变患者的心血管磁共振成像结果
J Cardiovasc Magn Reson. 2015 Oct 24;17:89. doi: 10.1186/s12968-015-0192-3.
7
Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.肥厚型心肌病的收缩期和舒张期心肌力学及其与肥厚程度、替代性纤维化和间质纤维化的关系。
Int J Cardiovasc Imaging. 2015 Dec;31(8):1603-10. doi: 10.1007/s10554-015-0720-0. Epub 2015 Jul 26.
8
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.应用三维斑点追踪超声心动图研究心肌整体和局部力学与肥厚型心肌病心肌肥厚和纤维化的关系。
Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.
9
Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.肥厚型心肌病病程中的左心房功能:与左心室肥厚及纤维化的关系
Invest Radiol. 2017 Mar;52(3):177-185. doi: 10.1097/RLI.0000000000000326.
10
Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.肌节基因突变对肥厚型心肌病患者左心房功能的影响。
Cardiovasc Ultrasound. 2021 Jan 6;19(1):4. doi: 10.1186/s12947-020-00233-y.

引用本文的文献

1
Investigating the Anrep Effect in Hypertrophic Obstructive Cardiomyopathy With Invasive Pressure-Volume Analysis.通过有创压力-容积分析研究肥厚性梗阻性心肌病中的安雷普效应。
JACC Adv. 2025 Apr 18;4(5):101728. doi: 10.1016/j.jacadv.2025.101728.
2
Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities.肥厚型心肌病中的机械-能量解偶联:病理生理机制与治疗机遇
J Mol Cell Cardiol Plus. 2023 May 6;4:100036. doi: 10.1016/j.jmccpl.2023.100036. eCollection 2023 Jun.
3
Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease.

本文引用的文献

1
Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.舒张功能异常作为荷兰肌球蛋白结合蛋白C始祖突变型肥厚型心肌病的首要特征。
JACC Cardiovasc Imaging. 2009 Jan;2(1):58-64. doi: 10.1016/j.jcmg.2008.08.003.
2
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype.基因型正常表型肥厚型心肌病的延迟钆增强心血管磁共振成像
J Cardiovasc Magn Reson. 2008 Dec 16;10(1):58. doi: 10.1186/1532-429X-10-58.
3
Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study.
临床下肌节相关肥厚型心肌病表型谱及向显性疾病的转变。
Circ Genom Precis Med. 2024 Aug;17(4):e004580. doi: 10.1161/CIRCGEN.124.004580. Epub 2024 Jun 24.
4
Ion Channel Impairment and Myofilament Ca Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy.离子通道功能障碍和肌球蛋白钙敏化:肥厚型心肌病心律失常发生的两个并行机制。
Cells. 2021 Oct 18;10(10):2789. doi: 10.3390/cells10102789.
5
The role of echocardiography in management of hypertrophic cardiomyopathy.超声心动图在肥厚型心肌病管理中的作用。
J Echocardiogr. 2020 Jun;18(2):77-85. doi: 10.1007/s12574-019-00454-9. Epub 2019 Dec 19.
6
Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes.肥厚型心肌的细胞外基质会导致健康心肌细胞的收缩动力学受损。
JACC Basic Transl Sci. 2019 Jul 24;4(4):495-505. doi: 10.1016/j.jacbts.2019.03.004. eCollection 2019 Aug.
7
Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.肥厚型心肌病病理生理学中的冠状动脉血管。
Pflugers Arch. 2019 May;471(5):769-780. doi: 10.1007/s00424-018-2224-y. Epub 2018 Oct 29.
8
Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.肥厚型心肌病:肌节突变引发的恶性循环和继发疾病打击。
Antioxid Redox Signal. 2019 Aug 1;31(4):318-358. doi: 10.1089/ars.2017.7236. Epub 2018 Apr 11.
9
Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.肥厚型心肌病患者的左心室功能及其与心肌纤维化和运动耐量的关系。
Int J Cardiovasc Imaging. 2018 Jan;34(1):121-129. doi: 10.1007/s10554-017-1214-z. Epub 2017 Jul 26.
10
The systolic paradox in hypertrophic cardiomyopathy.肥厚型心肌病中的收缩期矛盾现象。
Open Heart. 2017 May 16;4(1):e000571. doi: 10.1136/openhrt-2016-000571. eCollection 2017.
与三维容积法相比的右心室功能半定量评估:一项心血管磁共振研究。
Eur Radiol. 2008 Nov;18(11):2399-405. doi: 10.1007/s00330-008-1017-7. Epub 2008 Jun 4.
4
Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.肌钙蛋白和α-原肌球蛋白中的扩张型和肥厚型心肌病突变对心脏细肌丝的钙亲和力具有相反的影响。
Circ Res. 2007 Dec 7;101(12):1266-73. doi: 10.1161/CIRCRESAHA.107.156380. Epub 2007 Oct 11.
5
Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.完整心肌细胞的完全舒张需要心肌肌球蛋白结合蛋白C。
Circ Res. 2007 Oct 26;101(9):928-38. doi: 10.1161/CIRCRESAHA.107.158774. Epub 2007 Sep 6.
6
Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation.心肌肌球蛋白结合蛋白C和心肌肌钙蛋白I在肌原纤维对蛋白激酶A磷酸化的力反应中的不同作用。
Circ Res. 2007 Aug 31;101(5):503-11. doi: 10.1161/CIRCRESAHA.107.153650. Epub 2007 Jul 19.
7
Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects.在健康受试者中使用心脏磁共振成像评估衰老对左房室耦合和左心室充盈的影响。
Am J Cardiol. 2007 Jul 1;100(1):122-7. doi: 10.1016/j.amjcard.2007.02.060. Epub 2007 May 21.
8
Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro.钆增强磁共振成像用于体外检测和定量分析人类心肌纤维化
Int J Cardiovasc Imaging. 2008 Jan;24(1):61-8. doi: 10.1007/s10554-007-9223-y. Epub 2007 Apr 12.
9
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.肥厚型心肌病突变携带者经心脏磁共振成像检测到的左心室下间隔结构异常。
J Am Coll Cardiol. 2006 Dec 19;48(12):2518-23. doi: 10.1016/j.jacc.2006.08.036. Epub 2006 Nov 28.
10
Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i.肌钙蛋白I中肥厚型心肌病突变的计算模拟:肌丝钙敏感性增加对等长力、ATP酶和细胞内钙离子浓度的影响
J Biomech. 2007;40(9):2044-52. doi: 10.1016/j.jbiomech.2006.09.026. Epub 2006 Nov 30.